Trade Setup for March 18: Nifty rebounds for second day running but oil poses a challenge
Going ahead, the near-term recovery could sustain, but further upside will hinge on easing geopolitical risks.
admin
How to invest in ETFs using HDFC Sky?
ETFs offer a simple way to build a diversified investment portfolio without managing individual stocks.
Swan Defence promoter to sell 5% stake via OFS, up to 26 lakh shares on offer
Hazel Infra Ltd plans to sell 26.38 lakh shares of Swan Defence and Heavy Industries Ltd via OFS from March 18 to March 24, 2026. Shares of Swan Defence and Heavy Industries ended marginally higher on Tuesday, March 17, by…
Subex wins ₹24-crore EAM contract from leading North African telecom operator
The 9-year project covers the deployment of Subex’s HyperSense solutions across the operator’s telecom network, fibre, IT, and data centre assets. Shares of Subex Ltd ended at ₹7.99, down by ₹0.010, or 0.13%, on the BSE today, March 17.
Varun Beverages arm to acquire 100% stake in South Africa’s Crickley Dairy for ₹131 crore
Shares of Varun Beverages Ltd ended at ₹406.50, down by ₹1.00, or 0.25%, on the BSE. On Monday (March 16), brokerage firm BoFA Securities maintained its ‘buy’ rating on Varun Beverages, along with a price target of ₹550, which implies…
Tamilnadu Petroproducts shuts plant due to LPG shortage, cites force majeure
The company said the shutdown is a force majeure event and that it cannot quantify the impact at this stage. It is taking steps to restart operations and will update exchanges on any material developments. Shares of Tamilnadu Petroproducts closed…
Ceigall India wins Ludhiana street projects worth ₹207 crore
Subsidiary CIPPL bags lowest bids worth ₹207 crore combined on Punjab e-procurement portal.
Shree Cement named preferred bidder for 373-hectare Andhra Pradesh limestone block
The e-auction was conducted by the government of Andhra Pradesh for the grant of a mining lease for the specified block. Shares of Shree Cement Ltd ended at ₹23,696.65, up by ₹357.30, or 1.53%, on the BSE.
AstraZeneca Pharma India gets approval for Imfinzi in liver cancer treatment
AstraZeneca Pharma India got CDSCO approval to market Durvalumab for unresectable hepatocellular carcinoma, expanding its oncology portfolio. Shares closed 0.33% higher at ₹8,403.
BEL bags ₹1,011 crore in fresh defence orders, boosting order book
BEL secured orders worth ₹1,011 crore since Feb 25, 2026, including communication equipment, radar systems, and software. BEL reported Q3 revenue of ₹7,122 crore, up 23.7%.